190 related articles for article (PubMed ID: 34017336)
1. Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
Ehlers AM; den Hartog Jager CF; Kardol-Hoefnagel T; Katsburg MMD; Knulst AC; Otten HG
Front Immunol; 2021; 12():660037. PubMed ID: 34017336
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation.
Lundkvist A; Hörling J; Athlin L; Rosén A; Niklasson B
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1303-10. PubMed ID: 7687648
[TBL] [Abstract][Full Text] [Related]
3. B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.
Moosmann A; Khan N; Cobbold M; Zentz C; Delecluse HJ; Hollweck G; Hislop AD; Blake NW; Croom-Carter D; Wollenberg B; Moss PA; Zeidler R; Rickinson AB; Hammerschmidt W
Blood; 2002 Sep; 100(5):1755-64. PubMed ID: 12176897
[TBL] [Abstract][Full Text] [Related]
4. Distinction between peanut allergy and tolerance by characterization of B cell receptor repertoires.
Ehlers AM; den Hartog Jager CF; Knulst AC; Otten HG
Allergy; 2021 Sep; 76(9):2753-2764. PubMed ID: 33969502
[TBL] [Abstract][Full Text] [Related]
5. Expression of antigens of the carcinoembryonic antigen family on B cell lymphomas and Epstein-Barr virus immortalized B cell lines.
Khan WN; Hammarström S; Ramos T
Int Immunol; 1993 Mar; 5(3):265-70. PubMed ID: 8385475
[TBL] [Abstract][Full Text] [Related]
6. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
7. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
8. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
9. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
10. Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.
Lai J; Tan WJ; Too CT; Choo JA; Wong LH; Mustafa FB; Srinivasan N; Lim AP; Zhong Y; Gascoigne NR; Hanson BJ; Chan SH; Chen J; MacAry PA
Blood; 2016 Sep; 128(10):1396-407. PubMed ID: 27338099
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen.
Nagatsuka Y; Yamaki M; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
Virus Res; 1996 Jul; 43(1):57-68. PubMed ID: 8822634
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220.
Qualtiere LF; Decoteau JF; Hassan Nasr-el-Din M
J Gen Virol; 1987 Feb; 68 ( Pt 2)():535-43. PubMed ID: 2434608
[TBL] [Abstract][Full Text] [Related]
14. Production of human monoclonal antibodies by the epstein-barr virus method.
Steinitz M
Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical characterisation of structure and allergenicity of peanut 2S albumins using different formats of immunoassays.
Bernard H; Drumare MF; Guillon B; Paty E; Scheinmann P; Wal JM
Anal Bioanal Chem; 2009 Sep; 395(1):139-46. PubMed ID: 19462164
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
17. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens.
Pasha RP; Roohi A; Shokri F
Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
19. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
